联合灌注与高b值扩散MRI判断胶质母细胞瘤预后并预测失败模式
52例新诊断胶质母细胞瘤患者在放化疗前接受MRI,基于高b值扩散与动态对比增强灌注成像定义高细胞密度体积(TVHCV)和脑血容量增高体积(TVCBV)。TVHCV及TVHCV与TVCBV重叠体积与无进展生存期相关,联合增强肿瘤体积、TVCBV和TVHCV可较单个亚体积更好地预测进展位置。
要点
- TVHCV与TVCBV空间分布不同,平均重叠仅21%。
- 多因素分析中TVHCV是预后最差的影像学定义变量。
- TVHCV与TVCBV的交集体积特别容易包含进展。
核心结论
- TVHCV以及TVHCV与TVCBV的重叠体积是无进展生存期的预后因素。
- 钆增强肿瘤体积、TVCBV和TVHCV的组合能比单个亚体积更好地预测肿瘤进展位置。
- 对这些亚体积进行放疗剂量提升可能是一种有前景的治疗策略。
研究设计与样本
- 52例新诊断胶质母细胞瘤患者在放化疗前接受磁共振成像。
- 增强肿瘤体积排除手术腔,高细胞密度体积(TVHCV)和脑血容量增高体积(TVCBV)分别用常规钆增强T1加权图像、高b值(3000 s/mm2)扩散加权图像和T1加权动态对比增强图像的脑血容量图定义。
- 用Cox比例风险模型分析影像表型肿瘤体积对无进展生存期的预测,并分析对进展位置(失败模式肿瘤体积)的预测。
主要发现
- 队列中位无进展生存期为13个月。
- TVCBV与TVHCV空间分布不同,平均重叠仅21%。
- 单因素分析显示年龄增大、放疗剂量降低、TVHCV较大以及TVHCV与TVCBV重叠较大与较差的无进展生存期显著相关。
- 多因素分析确定TVHCV是预后最差的影像学定义变量。
- 排除手术腔的增强肿瘤体积以及TVHCV与TVCBV的并集高度可能包含失败模式肿瘤体积,TVHCV与TVCBV的交集体积特别容易包含进展。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Advanced imaging modalities such as high b-value diffusion and dynamic contrast enhancement magnetic resonance imaging have the potential to improve the clinical management of glioblastoma by informing prognosis, predicting sites of progression, and guiding dose-escalated radiation to maximize tumor control and minimize toxicity. METHODS AND MATERIALS: Fifty-two patients with de novo glioblastoma underwent magnetic resonance imaging before chemoradiation therapy. Enhanced tumor volumes (TVs), excluding the surgical cavity, hypercellularity (TVHCV) and increased cerebral blood volume (TVCBV) were defined using conventional gadolinium-enhanced T1-weighted images, high b-value (3000 s/mm2) diffusion-weighted images, and cerebral blood volume maps from T1-weighted dynamic contrast enhancement images, respectively. The image-phenotype TVs were analyzed for prediction of progression-free survival (Cox proportional hazard models), and sites of progression (pattern of failure tumor volume). RESULTS: The median progression-free survival (PFS) of the cohort was 13 months. The TVCBV and TVHCV were spatially distinct, with a mean overlap of only 21%. Univariate analysis showed that increasing age, decreasing radiation dose, larger TVHCV, and larger overlap of TVHCV and TVCBV were significantly associated with inferior PFS. Multivariate analysis identified that TVHCV was the most adversely prognostic imaging-defined variable. Enhanced TVs, excluding the surgical cavity, and the union of TVHCV and TVCBV showed a high likelihood of containing the pattern of failure tumor volume, and the volume composed of the intersection of TVHCV and TVCBV had an especially high likelihood of progression. CONCLUSIONS: TVHCV and the overlap of TVHCV and TVCBV are prognostic for PFS. Combinations of gadolinium-enhanced TVs, TVCBV, and TVHCV could predict tumor progression locations better than could individual subvolumes. Radiation dose escalation to these subvolumes could be a promising therapeutic strategy.
引用
- Wahl DR, Kim MM, Aryal MP, et al. Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma. Int J Radiat Oncol Biol Phys. 2018. PMID: 29980414. doi:10.1016/j.ijrobp.2018.04.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。